News specifically tailored to medical oncologists
A new pathway to ‘reprogram’ killer cells
The so-called natural killer (NK) cells are cells of the innate immune system that recognise…
Browsing: Medical Oncology
Long-term survival rate for subset of patients with advanced melanoma following BRAF- and MEK-targeted treatment combination higher than historical rate
According to the National Cancer Institute’s SEER data, the five-year survival rate for metastatic melanoma among…
Cell death or cancer growth: A question of cohesion
Activation of CD95, a receptor found on all cancer cells, triggers programmed cell death -…
Scientists obtained new compounds with potential anti-tumour effect from sea sponge
Chemists from Far Eastern Federal University’s School of Natural Sciences (SNS FEFU), Russia, developed a…
Eliminating common bacterial infection significantly decreases gastric cancer risk
While it is well known within the medical community that there is a link between…
A step closer to cancer precision medicine
Researchers from the Faculty of Medicine and the Institute for Molecular Medicine (FIMM) at the…
Protected: Boehringer Ingelheim Advances First Pan-KRAS Inhibitor BI 1701963 into Clinical Testing
This content is password-protected. To view it, please enter the password below. Password:
The ways astronauts prep for spaceflight could benefit cancer patients
During spaceflight, astronauts experience similar physical stress as cancer patients undergoing treatments such as chemotherapy,…
Young male cancer survivors may benefit from testosterone replacement
In young male cancer survivors with low testosterone levels, testosterone replacement therapy is associated with…
Bowel cancer rates after colonoscopy vary by provider
A colonoscopy is the main test used to detect bowel cancer, but like most tests,…